JP2016506905A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506905A5
JP2016506905A5 JP2015552077A JP2015552077A JP2016506905A5 JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5 JP 2015552077 A JP2015552077 A JP 2015552077A JP 2015552077 A JP2015552077 A JP 2015552077A JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5
Authority
JP
Japan
Prior art keywords
azide
saccharide
group
spacer
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015552077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016506905A (ja
JP6719209B2 (ja
Filing date
Publication date
Priority claimed from GBGB1300707.5A external-priority patent/GB201300707D0/en
Application filed filed Critical
Publication of JP2016506905A publication Critical patent/JP2016506905A/ja
Publication of JP2016506905A5 publication Critical patent/JP2016506905A5/ja
Application granted granted Critical
Publication of JP6719209B2 publication Critical patent/JP6719209B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015552077A 2013-01-15 2014-01-13 シクロアルキン誘導体化糖類 Active JP6719209B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1300707.5A GB201300707D0 (en) 2013-01-15 2013-01-15 Compounds and processes
GB1300707.5 2013-01-15
PCT/EP2014/050483 WO2014111344A1 (en) 2013-01-15 2014-01-13 Cycloalkyne derivatized saccharides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018246761A Division JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類

Publications (3)

Publication Number Publication Date
JP2016506905A JP2016506905A (ja) 2016-03-07
JP2016506905A5 true JP2016506905A5 (enExample) 2017-02-09
JP6719209B2 JP6719209B2 (ja) 2020-07-08

Family

ID=47758014

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015552077A Active JP6719209B2 (ja) 2013-01-15 2014-01-13 シクロアルキン誘導体化糖類
JP2018246761A Withdrawn JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類
JP2020050828A Active JP7036854B2 (ja) 2013-01-15 2020-03-23 シクロアルキン誘導体化糖類

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018246761A Withdrawn JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類
JP2020050828A Active JP7036854B2 (ja) 2013-01-15 2020-03-23 シクロアルキン誘導体化糖類

Country Status (16)

Country Link
US (2) US11135300B2 (enExample)
EP (1) EP2945641B1 (enExample)
JP (3) JP6719209B2 (enExample)
CN (1) CN105377282B (enExample)
BR (1) BR112015016817B1 (enExample)
CA (1) CA2897348C (enExample)
CY (1) CY1122822T1 (enExample)
DK (1) DK2945641T3 (enExample)
ES (1) ES2774729T3 (enExample)
GB (1) GB201300707D0 (enExample)
HR (1) HRP20200351T1 (enExample)
LT (1) LT2945641T (enExample)
PL (1) PL2945641T3 (enExample)
PT (1) PT2945641T (enExample)
SI (1) SI2945641T1 (enExample)
WO (1) WO2014111344A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201300707D0 (en) * 2013-01-15 2013-02-27 Novartis Ag Compounds and processes
CN108697741B (zh) * 2016-03-04 2023-04-14 悠绿那股份有限公司 抗病毒剂及抗病毒用食品
US11998599B2 (en) 2016-12-30 2024-06-04 Vaxcyte, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US12050220B2 (en) 2018-02-05 2024-07-30 University Of Miyazaki Cell labeling agent and cell labeling kit
CN112236457B (zh) 2018-06-14 2023-08-29 持田制药株式会社 新型交联海藻酸
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
JP2023538365A (ja) 2020-08-19 2023-09-07 バックスサイト・インコーポレイテッド 担体-タンパク質多糖結合方法
PH12023553205A1 (en) * 2021-05-28 2024-02-19 Pfizer Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
JP2024075506A (ja) * 2022-11-22 2024-06-03 ファイザー・インク コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0308768A (pt) * 2002-03-26 2005-02-15 Chiron Srl Sacarìdeos modificados possuindo estabilidade melhorada em água
MX2007005202A (es) * 2004-11-01 2007-07-09 Brigham & Womens Hospital Polisacaridos de estreptococo modificados y usos de los mismos.
GB0502095D0 (en) * 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
US8133515B2 (en) * 2007-11-21 2012-03-13 University Of Georgia Research Foundation, Inc. Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
ITVI20090234A1 (it) * 2009-09-25 2011-03-26 Termotecniche Fraccaro S R L Off Dispositivo per il riscaldamento di ambienti ad alta efficienza energetica, nonche' sistema riscaldante comprendente tale dispositivo
EP2515914A4 (en) * 2009-12-23 2013-09-11 Scripps Research Inst BIOCONJUGATION OF TYROSINE BY EYE REACTIONS IN AQUEOUS MEDIA
PL2563753T6 (pl) 2010-04-27 2016-05-31 Synaffix Bv Stopione związki cyklooktynu i ich zastosowanie w reakcjach typu "click" bez udziału metalu
WO2012017701A1 (ja) * 2010-08-05 2012-02-09 株式会社ミュージックゲート いびき防止マスク
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
CN103347862B (zh) 2010-09-27 2018-07-20 乔治亚大学研究基金公司 包含潜在的1,3-偶极-官能化合物的方法和由此制备的材料
US20120208722A1 (en) * 2010-10-19 2012-08-16 Richard Dluhy Surface enhanced raman spectroscopy platforms and methods
DK2721045T3 (en) * 2011-06-20 2017-07-24 Radiomedix Inc COMPOSITIONS, METHODS OF SYNTHESIS AND USE OF CARBOHYDRATE TARGETED AGENTS
BR112014013250A2 (pt) * 2011-12-01 2019-09-24 Angiochem Inc compostos com enzima alvo e usos dos mesmos
GB201300707D0 (en) * 2013-01-15 2013-02-27 Novartis Ag Compounds and processes

Similar Documents

Publication Publication Date Title
JP2016506905A5 (enExample)
WO2008083174A3 (en) Compositions and methods for the treatment of infections and tumors
HRP20200351T1 (hr) Cikloalkinski derivati saharida
CY1125006T1 (el) Λιπαρα οξεα και η χρηση τους σε συνδυασμο με βιομορια
WO2018098269A3 (en) Peptide-containing linkers for antibody-drug conjugates
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
WO2009082819A8 (en) Novel lupane derivatives
EP3318562A3 (en) Benzylbenzene derivatives and methods of use
WO2009106980A3 (en) Indazole derivatives
JP2012528865A5 (enExample)
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
WO2007062107A3 (en) Immunostimulatory oligoribonucleotides
CL2008003153A1 (es) Compuestos espiro condensados, agonistas de gpr40: composicion farmaceutica que comprende a uno de los compuestos; y el uso de los compuestos en la preparacion de medicamentos para el tratamiento de la diabetes, hiperglicemia, alteracion de tolerancia a la glucosa en ayuna, entre otras.
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2009088838A3 (en) Triarylmethane analogs and their use in treating cancers
JP2017505777A5 (enExample)
WO2015066053A8 (en) Targeted therapeutics
JP2015501329A5 (enExample)
Tabakmakher et al. Normonanchocidins A, B and D, new pentacyclic guanidine alkaloids from the Far-Eastern marine sponge Monanchora pulchra
US20230382945A1 (en) Therapeutic agents and methods
RU2013136895A (ru) Новое бициклическое соединение или его соль
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
WO2009102808A3 (en) Doxorubicin adjuvants to reduce toxicity and methods for using the same